title: Ventricular Recovery and Pump Explantation in Patients Supported by Left Ventricular Assist Devices: A Systematic Review.
abstract: Several studies have reported that a portion of patients who exhibit cardiac recovery during left ventricular assist device (LVAD) support can have their device explanted with reasonable long-term survival. The aim of this systematic review is to assess the survival and cardiac function in patients with explanted LVADs from the current literature. Electronic search was performed to identify all studies in English literature assessing LVAD explantation. All identified articles were systematically assessed using the inclusion and exclusion criteria. Selected studies were subjected to quantitative assessment. From 5 electronic databases, 11 studies (213 patients) were included. Pooled mean perioperative mortality rate of those explanted was 9.2% (95% CI, 5.0-14.5%; I = 0). Pooled mean late mortality rate was 15% (95% CI, 9.0-22.1%; I = 31%). The pooled 1, 5, and 10 year survival postexplant was 91, 76, and 65.7%, respectively. Pooled postweaning freedom from heart failure (HF) recurrence reached 81.3%. Subset analysis demonstrated that patients explanted from a continuous-flow LVAD versus pulsatile LVAD had a lower rate of HF recurrence (6.6 vs. 28.3%, p = 0.03) and LVAD reimplantation (7.5 vs. 37%, p = 0.001). Before LVAD explantation, overall mean left ventricular ejection fraction (LVEF) was 49%. Weighted pooled early and late postexplantation mean LVEF was 47.3 and 41.2%, respectively. Late postexplantation LVEF was significantly higher in the continuous-flow versus pulsatile LVAD subgroup (41.5 vs. 24%, p = 0.001). This review shows encouraging safety and 10 year survival outcomes after explantation of LVADs in carefully selected patients, with rates better than expected after a heart transplant. Recovery of the native heart is the most desirable clinical outcome in patients supported with LVADs and should be actively sought.
authors.affiliation: From the *The Collaborative Research (CORE) Group, Macquarie University, Sydney, Australia; †Faculty of Medicine, University of Sydney, Sydney, Australia; ‡Faculty of Medicine, University of New South Wales (UNSW), Sydney, Australia; §Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, Australia; and ¶ Division of Cardiac Surgery, University of Rochester, Rochester, New York.
authors.forename: Kevin
authors.initials: K
authors.lastname: Phan
authors.forename: Ya Ruth
authors.initials: YR
authors.lastname: Huo
authors.forename: Dong Fang
authors.initials: DF
authors.lastname: Zhao
authors.forename: Tristan D
authors.initials: TD
authors.lastname: Yan
authors.forename: Vakhtang
authors.initials: V
authors.lastname: Tchantchaleishvili
mesh_terms: D020878:Device Removal / Q000401:mortality*; D005260:Female; D006333:Heart Failure / Q000601:surgery; D006353:Heart-Assist Devices / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome